A Consecutive Ring-Expansion Strategy towards the Macrocyclic Core of the Solomonamide Natural Products

Zhongzhen Yang; Christopher R. B. Swanson; William P. Unsworth

doi:10.1055/a-1932-9717

Synlett, Table of Contents

Synlett 2023; 34(14): 1694-1698
DOI: 10.1055/a-1932-9717

letter

Published as part of the Special Section 13th EuCheMS Organic Division Young Investigator Workshop

A Consecutive Ring-Expansion Strategy towards the Macrocyclic Core of the Solomonamide Natural Products

Zhongzhen Yang

,

Christopher R. B. Swanson

,

William P. Unsworth ∗

Abstract

All articles of this category

Abstract

A synthetic strategy based on the application of three consecutive ring-expansion reactions has been used in the synthesis of analogues of the macrocyclic core of the solomonamide natural products. Starting from a simple, readily available tetrahydrocarbazole, oxidative ring expansion is followed by two further 3- and 4-atom ring-expansion reactions, enabling the insertion of amino acid and hydroxy acid derived linear fragments into 15- to 17-membered-ring-enlarged macrocyclic products.

Key words

macrocycles - medium-sized rings - ring expansion - natural product analogues - lactams - lactones - solomonamides

Full Text

References

References and Notes
1 Since completing this study, C. R. B. Swanson has relocated to a different institution: Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN (UK).
2 Festa C, De Marino S, Sepe V, D’Auria MV, Bifulco G, Débitus C, Bucci M, Vellecco V, Zampella A. Org. Lett. 2011; 13: 1532
3 Kashinath K, Jachak GR, Athawale PR, Marelli UK, Gonnade RG, Reddy DS. Org. Lett. 2016; 18: 3178
4 Jachak GR, Athawale PR, Agarwal H, Barthwal MK, Lauro G, Bifulco G, Reddy DS. Org. Biomol. Chem. 2018; 16: 9138

5a Kashinath K, Vasudevan N, Reddy DS. Org. Lett. 2012; 14: 6222
5b Vasudevan N, Kashinath K, Reddy DS. Org. Lett. 2014; 16: 6148
5c Kashinath K, Dhara S, Reddy DS. Org. Lett. 2015; 17: 2090
5d Jachak GR, Athawale PR, Choudhury R, Kashinath K, Reddy DS. Chem. Asian J. 2019; 14: 4572

6a Kavitha N, Kumar VP, Chandrasekhar S. Tetrahedron Lett. 2013; 54: 2128
6b Kavitha N, Chandrasekhar S. Org. Biomol. Chem. 2015; 13: 6242
6c Cheng-Sánchez I, García-Ruiz C, Sarabia F. Tetrahedron Lett. 2016; 57: 3392
6d Cheng-Sánchez I, Carrillo P, Sánchez-Ruiz A, Martínez-Poveda B, Quesada AR, Medina M. Á, López-Romero JM, Sarabia F. J. Org. Chem. 2018; 83: 5365
6e Carrillo P, Martínez-Poveda B, Cheng-Sánchez I, Guerra J, Tobia C, López-Romero JM, Sarabia F, Medina MA, Quesada AR. Mar. Drugs 2019; 17: 228

7 Saridakis I, Kaiser D, Maulide N. ACS Cent. Sci. 2020; 6: 1869
8 Practical Medicinal Chemistry with Macrocycles. Marsault E, Peterson ML. Wiley; Hoboken: 2017

9a Gradillas A, Pérez-Castells J. Angew. Chem. Int. Ed. 2006; 45: 6086
9b Lecourt C, Dhambri S, Allievi L, Sanogo Y, Zeghbib N, Ben Othman R, Lannou M.-I, Sorin G, Ardisson J. Nat. Prod. Rep. 2018; 35: 105

For papers discussing the influence of ring size on end-to-end cyclisation reactions, see:

10a Illuminati G, Mandolini L. Acc. Chem. Res. 1981; 14: 95
10b Fastrez J. J. Phys. Chem. 1989; 93: 2635
10c Collins JC, James K. Med. Chem. Commun. 2012; 3: 1489
10d Kurouchi H, Ohwada T. J. Org. Chem. 2020; 85: 876

For general perspective on macrocycle synthesis, see:

10e Marsault E, Peterson ML. J. Med. Chem. 2011; 54: 1961
10f Yudin AK. Chem. Sci. 2015; 6: 30
10g Mortensen KT, Osberger TJ, King TA, Sore HF, Spring DR. Chem. Rev. 2019; 119: 10288
10h Appavoo SD, Huh S, Diaz DB, Yudin AK. Chem. Rev. 2019; 119: 9724
10i Smolyar IV, Yudin AK, Nenajdenko VG. Chem. Rev. 2019; 119: 10032

11 For a review on consecutive ring-expansion reactions, see: Stephens TC, Unsworth WP. Synlett 2020; 31: 133

For reviews on ring expansion, see:

12a Hesse M. In Ring Enlargement in Organic Chemistry. Wiley-VCH; Weinheim: 1991
12b Unsworth WP, Donald JR. Chem. Eur. J. 2017; 23: 8780
12c Prantz K, Mulzer J. Chem. Rev. 2010; 110: 3741
12d Clarke AK, Unsworth WP. Chem. Sci. 2020; 11: 2876

For selected recent examples, see:

13a Li L, Li Z.-L, Wang F.-L, Guo Z, Cheng Y.-F, Wang N, Dong X.-W, Fang C, Liu J, Hou C, Tan B, Liu X.-Y. Nat. Commun. 2016; 7: 13852
13b Mendoza-Sanchez R, Corless VB, Nguyen QN. N, Bergeron-Brlek M, Frost J, Adachi S, Tantillo DJ, Yudin AK. Chem. Eur. J. 2017; 23: 13319
13c Costil R, Lefebvre Q, Clayden J. Angew. Chem. Int. Ed. 2017; 56: 14602
13d Loya DR, Jean A, Cormier M, Fressigné C, Nejrotti S, Blanchet J, Maddaluno J, De Paolis M. Chem. Eur. J. 2018; 24: 2080
13e Lawer A, Rossi-Ashton JA, Stephens TC, Challis BJ, Epton RG, Lynam JM, Unsworth WP. Angew. Chem. Int. Ed. 2019; 58: 13942
13f Grintsevich S, Sapegin A, Reutskaya E, Peintner S, Erdélyi M, Krasavin M. Eur. J. Org. Chem. 2020; 5664
13g Shang J, Thombare VJ, Charron CL, Wille U, Hutton C. Chem. Eur. J. 2021; 26: 1620

14a Kitsiou C, Hindes JJ, l’Anson P, Jackson P, Wilson TC, Daly EK, Felstead HR, Hearnshaw P, Unsworth WP. Angew. Chem. Int. Ed. 2015; 54: 15794
14b Baud LG, Manning MA, Arkless HL, Stephens TC, Unsworth WP. Chem. Eur. J. 2017; 23: 2225
14c Stephens TC, Lodi M, Steer A, Lin Y, Gill M, Unsworth WP. Chem. Eur. J. 2017; 23: 13314
14d Stephens TC, Lawer A, French T, Unsworth WP. Chem. Eur. J. 2018; 24: 13947
14e Lawer A, Epton RG, Stephens TC, Palate KY, Lodi M, Marotte E, Lamb KJ, Sangha JK, Lynam J, Unsworth WP. Chem. Eur. J. 2020; 26: 12674
14f Palate KY, Epton RG, Whitwood AC, Lynam JM, Unsworth WP. Org. Biomol. Chem. 2021; 19: 1404
14g Palate KY, Yang Z, Whitwood AC, Unsworth WP. RSC Chem. Biol. 2022; 3: 334

15 For the application of SuRE reactions by another research group, see: Zhao C, Ye Z, Ma Z.-X, Wildman SA, Blaszczyk SA, Hu L, Guizei IA, Tang W. Nat. Commun. 2019; 10: 4015
16 Dolby LJ, Booth DL. J. Am. Chem. Soc. 1966; 88: 1049

For useful perspective on how resonance and conformation can affect the reactivity of amide derivatives, see:

17a Liu C, Szostak M. Chem. Eur. J. 2017; 23: 7157
17b Li G, Ma S, Szostak M. Trends Chem. 2020; 2: 914

18 In the cases of products 28 and 33 (both prepared from enantiopure proteinogenic amino acids), the enantiopurity of the products was not measured in this study, but epimerisation is considered to be unlikely based on our previous studies (ref. 14), in which such epimerisation was not observed in related systems.
19 Representative Procedure for SuRE Method A (Synthesis of 28) 3,4,5,6-Tetrahydro-1H-(1)-benzazonin-2,7-dione 8 (406.4 mg, 2.00 mmol), DMAP (24.4 mg, 0.200 mmol), and pyridine (0.970 mL, 12.0 mmol) in dry DCM (10 mL) under an argon atmosphere were stirred at RT for 30 min. Next, a solution of acid chloride (6.0 mmol, 3.0 equiv., prepared from Cbz-proline using the procedure described in the Supporting Information) in dry DCM (10 mL) was added, and the resulting mixture was heated at reflux (50 °C) for 18 h. The solvent was then concentrated in vacuo, loaded onto a short silica plug and eluted with ethyl acetate, to remove majority of excess carboxylic acid and pyridine residues, and concentrated in vacuo. This material was redissolved in MeOH (20 mL) and placed under an argon atmosphere. Palladium on carbon (200 mg, 10% Pd on carbon) was added, and the reaction vessel was backfilled with hydrogen (via balloon) several times, then stirred at RT under a slight positive pressure of hydrogen (balloon) for 1 h. The reaction was then purged with argon, filtered through Celite, washed with methanol, and the solvent was removed in vacuo. Purification by flash column chromatography (SiO₂, ethyl acetate) afforded the title compound as a colorless oil (414 mg, 69% over 2 steps from 8) which exists as a 5:1 mixture of rotamers in solution in CDCl₃; [α]_D ²³ –312.13 (c = 1.0, CHCl₃); R_f = 0.23 (ethyl acetate). IR (neat) ν_max = 3252, 2948, 2242, 1691, 1672, 1602, 1505, 1442, 1299, 1238, 910, 756, 725, 644, 580 cm^–1. ¹H NMR (400 MHz, CDCl₃): δ = 9.43 (s, 1 H, NH, major rotamer), 9.34 (s, 1 H, NH, minor rotamer), 7.77–7.73 (m, 1 H, PhCH, major rotamer), 7.42–7.28 (m, 2 H, PhCH, both rotamers), 7.20–7.14 (m, 1 H, PhCH, minor rotamer), 7.07 (td, J = 7.6, 1.0 Hz, 1 H, PhCH, major rotamer), 4.31–4.20 (m, 1 H, NCHCO, both rotamers), 3.78 (dt, J = 10.1, 7.0 Hz, 1 H, NCH₂, major rotamer), 3.60 (ddd, J = 11.5, 7.3, 4.3 Hz, 1 H, NCH₂, minor rotamer), 3.55–3.44 (m, 1 H, NCH₂, both rotamers), 3.07–2.78 (m, 2 H, CH₂, both rotamers), 2.68–2.49 (m, 1 H, CH₂, major rotamer), 2.36–2.01 (m, 4 H, CH₂, both rotamers), 2.02–1.61 (m, 5 H, CH₂, both rotamers). ¹³C NMR (100 MHz, CDCl₃) for the major rotamer only: δ = 207.2 (CO), 173.4 (CO), 172.8 (CO), 134.8 (PhC), 133.0 (PhC), 131.4 (PhCH), 126.9 (PhCH), 124.5 (PhCH), 124.1 (PhCH), 62.6 (COCHN), 47.0 (CH₂), 41.8 (CH₂), 35.1 (CH₂), 28.4 (CH₂), 25.3 (CH₂), 22.6 (CH₂), 22.1 (CH₂). Diagnostic ¹³C NMR resonances for the minor rotamer: δ = 204.8 (CO), 172.6 (CO), 172.3 (CO), 135.9 (PhC), 133.6 (PhC), 127.9 (PhCH), 126.0 (PhCH), 125.5 (PhCH), 61.4 (COCHN), 38.5 (CH₂), 31.9 (CH₂), 31.6 (CH₂), 23.6 (CH₂), 23.0 (CH₂), 21.2 (CH₂). HRMS (ESI): m/z calcd for C₁₇H₂₀N₂NaO₃: 323.1366; found [MNa]⁺: 323.1362 (1.3 ppm error). For spectroscopic data and procedures for all novel compounds prepared in this manuscript, see the Supporting Information.

Supplementary Material

Supporting Information